- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Wenhu Liu
Total 914 results
-
Balgrist University HospitalStiftung für Rheumaforschung Zurich; Stiftung Marie-Lou Ringgenberg BernCompletedOsteoarthritis, KneeSwitzerland
-
David Pei-Cheng LinGrape King Bio Ltd.CompletedDry Eye | Supplement
-
Kai Lin Xu; Jun Nian ZhengiCarTAB BioMed Inc.UnknownRecurrent or Refractory B Cell MalignancyChina
-
Li HuipingNot yet recruiting
-
Li Xiao WeiNot yet recruitingHepatocellular Carcinoma With PVTTChina
-
Li-Jen HsinNot yet recruitingPain, Postoperative | Pain, Acute | Obstructive Sleep Apnea-hypopnea Syndrome
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA IndexChina
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Lei LiRecruitingCervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical CancerChina
-
Lei LiRecruitingRecurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility OutcomesChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Li-kun ChenRecruitingNon-small Cell Lung Cancer | Brain MetastasesChina
-
ShiYue LiRecruitingDiagnosis | Complication RateChina
-
Li Zhang, MDNot yet recruitingNon-small Cell Lung CancerChina
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Lei LiRecruitingEndometrial Neoplasms | SurvivalChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
Lei LiUnknownCervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic AccuracyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNAChina
-
Lei LiUnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasChemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 AntibodyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | ChineseChina
-
Lei LiUnknownEndometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial TissueChina
-
Rongrong LiUnknownIodine Excess in Pregnancy | Selenium Excess in Pregnancy | Iodine Deficiency in Pregnancy | Selenium Deficiency in Pregnancy
-
Lei LiUnknownEpithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | TumorigenesisChina
-
Lei LiUnknown
-
Lei LiUnknownUterine Cervical Neoplasms | SurvivalChina
-
Weiqin LiUnknownPancreatitis, Acute
-
Ankara UniversityAnkara Yildirim Beyazıt University; Saglik Bilimleri Universitesi; Liv Hospital...RecruitingChemotherapy Effect | Pleural Mesothelioma | Treatment ResponseTurkey
-
Lia BallyUniversity Hospital, Basel, SwitzerlandCompletedLiver Diseases | Diabetes Mellitus, Type 2 | Gastric Disease | Colon Disease | Insulin Therapy | Pancreatic Disease | Perioperative Hyperglycaemia | Elective Surgery | Closed-Loop Glucose Control | Artificial PancreasSwitzerland
-
XiaoXi LinCompleted
-
Pennington Biomedical Research CenterLeverage Innovation for Technology Transfer Fund (LSU LIFT2)CompletedPediatric ObesityUnited States
-
XiaoXi LinUnknownInfantile HemangiomaChina
-
Junqi NiuChinese Academy of SciencesUnknownLiver Diseases | Hepatitis C, Chronic | Interferon DeficiencyChina
-
LMU KlinikumMedtronic Bakken Research Center; Deutsches Zentrum für Herz-Kreislauf-Forschung...CompletedMyocardial Infarction | Autonomic Nervous System DiseasesGermany, Austria
-
SBÜ Dr. Sadi Konuk Eğitim ve Araştırma HastanesiIstinye University; Liv Hospital (Ulus)Completed
-
xiaohua liNot yet recruitingGastroesophageal Junction Cancer
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
Tsung-Ying LiRecruitingHemophilia | Vitamin D Deficiency | Body Composition | Sarcopenia | Osteoporosis | Hemophilic ArthropathyTaiwan
-
Lei LiRecruitingEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Homologous Recombination Repair Gene Mutation | Drug Resistance | Overall Survival | Progression-free Survival | Poly(ADP-ribose) Polymerase InhibitorChina
-
Lei LiRecruitingCervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection | Cancer Screening | Cervical CytologyChina
-
Zhen-Hai LuRecruitingAdvanced Rectal CancerChina
-
Li Zhang, MDNot yet recruiting
-
Lei LiRecruitingQuality of Life | Mortality | Pelvic Floor Disorders | Laparotomy | Laparoscopy | Cost-Benefit Analysis | Morbidity | Survival | Uterine Cervical NeoplasmChina
-
Lei LiRecruitingRecurrence | Uterine Cervical Neoplasms | Mortality | Laparotomy | Laparoscopy | SurvivalChina
-
LI-JU ChenCompletedHeart Failure | Thirst | SalivaTaiwan
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical CarcinomaChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
Lei LiUnknownCervical Cancer | Cervical Intraepithelial Neoplasia | DNA Methylation | Cytology | High-risk Human PapillomavirusChina
-
Lei LiUnknownQuestionnaire | China | Workplace Violence Against Physicians | National Survey | Obstetrics and Gynecology | Random SampleChina